Clinical Trial Update: A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella and Typhoid Fever [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 study evaluated the safety, reactogenicity, and immune response of the GVGH iNTS-TCV vaccine against invasive non-typhoidal Salmonella inf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Non-typhoidal Salmonella Infection
• Typhoid Fever

Drugs mentioned

• GVGH iNTS-TCV vaccine (iNTS-TCV vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Salmonella Infections | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-11-28